Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Revenue

In the year 2023, Arbutus Biopharma had annual revenue of $18.14M, a decrease of -53.51%. Revenue in the quarter ending December 31, 2023 was $2.15M, a -65.65% decrease year-over-year.

• Revenue (ttm): $18.14M
• Revenue Growth: -53.51%
• P/S Ratio: 27.61
• Revenue / Employee: $248,507
• Employees: 73
• Market Cap: 497.28M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	18.14M	-20.88M	-53.51%
Dec 31, 2022	39.02M	28.03M	255.11%
Dec 31, 2021	10.99M	4.07M	58.92%
Dec 31, 2020	6.91M	903.00K	15.02%
Dec 31, 2019	6.01M	66.00K	1.11%
Dec 31, 2018	5.95M	-4.76M	-44.44%
Dec 31, 2017	10.70M	9.21M	617.64%
Dec 31, 2016	1.49M	-21.79M	-93.59%
Dec 31, 2015	23.28M	8.32M	55.66%
Dec 31, 2014	14.95M	-512.00K	-3.31%
Dec 31, 2013	15.47M	1.36M	9.64%
Dec 31, 2012	14.11M	-2.71M	-16.10%
Dec 31, 2011	16.81M	-4.54M	-21.27%
Dec 31, 2010	21.35M	6.93M	48.00%
Dec 31, 2009	14.43M	2.70M	22.99%
Dec 31, 2008	11.73M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.